10 news items
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
STIM
15 May 24
Administration (FDA) for NeuroStar TMS (transcranial magnetic stimulation) as a first-line add-on for adolescents aged 15-21 with MDD (major depressive
Neuronetics Reports Record First Quarter 2024 Financial and Operating Results
STIM
7 May 24
, adjunct treatment for major depressive disorder in adolescents aged 15-21Launched second cohort within the "Better Me Guarantee
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
STIM
3 May 24
, Neuronetics' NeuroStar® Advanced Therapy system is today's leading transcranial magnetic stimulation (TMS) treatment for major depressive
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
STIM
1 May 24
, is committed to supporting adolescents facing major depressive disorder (MDD). NeuroStar TMS (transcranial magnetic stimulation) is uniquely poised
Neuronetics, Inc. Announces New Publication In Brain Stimulation Confirms Full TMS Treatment Course Is Vital
STIM
10 Apr 24
symptom improvement in major depressive disorder (MDD) is strongly predictive of response at the completion of transcranial magnetic stimulation (TMS
6pya1fdoe2ss2j9xj4ac1j0c4
STIM
10 Apr 24
concludes that while early symptom improvement in major depressive disorder (MDD) is strongly predictive of response at the completion of transcranial
iosayh3mgtpe8sc7q3exy 0hw6wzzx4t
INZY
MESO
PNTG
28 Mar 24
to Benzinga Pro.
Here’s the latest list of major overbought players in this sector
d8ybnh
STIM
27 Mar 24
, Neuronetics' NeuroStar® Advanced Therapy system is today's leading transcranial magnetic stimulation (TMS) treatment for major depressive
z7iffgm87wnvl9ghyqyzenkhdm4987qu0z 0wo2
STIM
25 Mar 24
clearance from the U.S. Food and Drug Administration (FDA) for NeuroStar Advanced Therapy for use as an adjunct for the treatment of major depressive
8w87gm
STIM
7 Mar 24
of addressing major depressive disorder (MDD), including treatment-resistant depression (TRD), a condition that presents substantial challenges in mental health
- Prev
- 1
- Next